Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS.

Vitour D, Dabo S, Ahmadi Pour M, Vilasco M, Vidalain PO, Jacob Y, Mezel-Lemoine M, Paz S, Arguello M, Lin R, Tangy F, Hiscott J, Meurs EF.

J Biol Chem. 2009 Aug 14;284(33):21797-809. doi: 10.1074/jbc.M109.018275. Epub 2009 Jun 22.

2.

Polo-box motif targets a centrosome regulator, RanGTPase.

Jang YJ, Ji JH, Ahn JH, Hoe KL, Won M, Im DS, Chae SK, Song S, Yoo HS.

Biochem Biophys Res Commun. 2004 Dec 3;325(1):257-64.

PMID:
15522227
3.

Plk1 activation by Ste20-like kinase (Slk) phosphorylation and polo-box phosphopeptide binding assayed with the substrate translationally controlled tumor protein (TCTP).

Johnson TM, Antrobus R, Johnson LN.

Biochemistry. 2008 Mar 25;47(12):3688-96. doi: 10.1021/bi702134c. Epub 2008 Feb 26.

PMID:
18298087
4.

The Plk1 Polo box domain mediates a cell cycle and DNA damage regulated interaction with Chk2.

Tsvetkov LM, Tsekova RT, Xu X, Stern DF.

Cell Cycle. 2005 Apr;4(4):609-17. Epub 2005 Apr 9.

PMID:
15876876
5.

Expression profiles of carp IRF-3/-7 correlate with the up-regulation of RIG-I/MAVS/TRAF3/TBK1, four pivotal molecules in RIG-I signaling pathway.

Feng H, Liu H, Kong R, Wang L, Wang Y, Hu W, Guo Q.

Fish Shellfish Immunol. 2011 Apr-May;30(4-5):1159-69. doi: 10.1016/j.fsi.2011.03.002. Epub 2011 Mar 6.

PMID:
21385615
6.

Regulation of I(kappa)B kinase complex by phosphorylation of (gamma)-binding domain of I(kappa)B kinase (beta) by Polo-like kinase 1.

Higashimoto T, Chan N, Lee YK, Zandi E.

J Biol Chem. 2008 Dec 19;283(51):35354-67. doi: 10.1074/jbc.M806258200. Epub 2008 Oct 27.

7.

Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions.

Reindl W, Yuan J, Krämer A, Strebhardt K, Berg T.

Chem Biol. 2008 May;15(5):459-66. doi: 10.1016/j.chembiol.2008.03.013.

8.

Ubiquitin-regulated recruitment of IkappaB kinase epsilon to the MAVS interferon signaling adapter.

Paz S, Vilasco M, Arguello M, Sun Q, Lacoste J, Nguyen TL, Zhao T, Shestakova EA, Zaari S, Bibeau-Poirier A, Servant MJ, Lin R, Meurs EF, Hiscott J.

Mol Cell Biol. 2009 Jun;29(12):3401-12. doi: 10.1128/MCB.00880-08. Epub 2009 Apr 20.

11.

The natural product Aristolactam AIIIa as a new ligand targeting the polo-box domain of polo-like kinase 1 potently inhibits cancer cell proliferation.

Li L, Wang X, Chen J, Ding H, Zhang Y, Hu TC, Hu LH, Jiang HL, Shen X.

Acta Pharmacol Sin. 2009 Oct;30(10):1443-53. doi: 10.1038/aps.2009.141.

12.

The scaffold protein TANK/I-TRAF inhibits NF-kappaB activation by recruiting polo-like kinase 1.

Zhang W, Wang J, Zhang Y, Yuan Y, Guan W, Jin C, Chen H, Wang X, Yang X, He F.

Mol Biol Cell. 2010 Jul 15;21(14):2500-13. doi: 10.1091/mbc.E09-08-0715. Epub 2010 May 19.

13.

Deficiency in chromosome congression by the inhibition of Plk1 polo box domain-dependent recognition.

Watanabe N, Sekine T, Takagi M, Iwasaki J, Imamoto N, Kawasaki H, Osada H.

J Biol Chem. 2009 Jan 23;284(4):2344-53. doi: 10.1074/jbc.M805308200. Epub 2008 Nov 25.

14.

Phosphopeptides with improved cellular uptake properties as ligands for the polo-box domain of polo-like kinase 1.

Richter S, Neundorf I, Loebner K, Gräber M, Berg T, Bergmann R, Steinbach J, Pietzsch J, Wuest F.

Bioorg Med Chem Lett. 2011 Aug 15;21(16):4686-9. doi: 10.1016/j.bmcl.2011.06.103. Epub 2011 Jun 30.

PMID:
21778054
15.

Identification of green tea catechins as potent inhibitors of the polo-box domain of polo-like kinase 1.

Shan HM, Shi Y, Quan J.

ChemMedChem. 2015 Jan;10(1):158-63. doi: 10.1002/cmdc.201402284. Epub 2014 Sep 5.

PMID:
25196850
16.

Hepatitis C virus reveals a novel early control in acute immune response.

Arnaud N, Dabo S, Akazawa D, Fukasawa M, Shinkai-Ouchi F, Hugon J, Wakita T, Meurs EF.

PLoS Pathog. 2011 Oct;7(10):e1002289. doi: 10.1371/journal.ppat.1002289. Epub 2011 Oct 13.

17.

A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1.

Reindl W, Strebhardt K, Berg T.

Anal Biochem. 2008 Dec 15;383(2):205-9. doi: 10.1016/j.ab.2008.08.014. Epub 2008 Aug 22.

PMID:
18793607
18.

[Screening and identification of Polo-like kinase 1 as a 14-3-3Zeta-interacting protein].

Du J, Cheng L, Chen LJ, Chen Y, An R.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Aug;28(8):804-7. Chinese.

PMID:
22863584
19.

Design, synthesis and biological evaluation of phosphopeptides as Polo-like kinase 1 Polo-box domain inhibitors.

Lin TY, Min HP, Jiang C, Niu MM, Yan F, Xu LL, Di B.

Bioorg Med Chem. 2018 Jul 23;26(12):3429-3437. doi: 10.1016/j.bmc.2018.05.014. Epub 2018 May 14.

PMID:
29807699
20.

Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK.

Guo B, Cheng G.

J Biol Chem. 2007 Apr 20;282(16):11817-26. Epub 2007 Feb 26.

Supplemental Content

Support Center